Related Experiment Video
Updated: Jun 18, 2025

07:51
Mesenteric Artery Contraction and Relaxation Studies Using Automated Wire Myography
Published on: September 22, 2011
28.5K
Carotid body plastic behavior: evidence for D2-H3 receptor-receptor interactions
Elena Stocco1,2,3, Aron Emmi1, Maria Martina Sfriso1
1Section of Human Anatomy, Department of Neuroscience, University of Padova, Padua, Italy.
Frontiers in Physiology
|July 29, 2024
Summary
Dopamine D2 receptors and histamine H3 receptors form heterodimers in the carotid body, suggesting a new mechanism for receptor interaction and potential therapeutic targets.
Area of Science:
- Neuroscience
- Cell Biology
- Pharmacology
Background:
- Dopamine D2 receptors (D2R) and histamine H3 receptors (H3R) are GPCRs known to form receptor-receptor interactions (RRIs).
- While D2R and H3R are present in the carotid body (CB), their heterodimerization has not been previously shown.
- CB function is critical for physiological responses, and understanding receptor interplay is key.
Purpose of the Study:
- To investigate the colocalization and heterodimerization of D2R and H3R in the carotid body.
- To provide evidence for D2R-H3R RRIs in the CB.
- To explore the potential functional implications of these interactions.
Main Methods:
- Dissection of carotid bodies from Sprague-Dawley rats and human donors.
- Immunohistochemistry and double immunofluorescence to detect D2R and H3R.
- In situ proximity ligation assay (PLA) followed by confocal microscopy to confirm RRIs.
Main Results:
- D2R and H3R were found to colocalize in the carotid body samples.
- Positive signals for D2R-H3R RRIs were confirmed using PLA.
- D2R-H3R heterodimers were primarily located in type I carotid body cells.
Conclusions:
- This study provides the first evidence of D2R-H3R heterodimerization in the carotid body.
- These RRIs may play a significant role in modulating carotid body cell function.
- Understanding these interactions could reveal new clinical implications for CB regulation.
Related Concept Videos
Cholinergic Receptors: Muscarinic
2.1K
The pharmacological actions of acetylcholine are elicited via its binding to two families of cholinergic receptors or cholinoceptors, namely, muscarinic and nicotinic receptors. Muscarinic receptors are G protein-coupled receptors and have five subtypes, M1–M5. All mAChR subtypes are activated by acetylcholine and blocked by the antagonist, atropine.
The subtypes M1, M3, and M5 couple with the Gq subunit and activate the phospholipase C (PLC) activity, mobilizing intracellular Ca2+....
The subtypes M1, M3, and M5 couple with the Gq subunit and activate the phospholipase C (PLC) activity, mobilizing intracellular Ca2+....
2.1K
Parasympathetic Signaling
1.8K
Parasympathetic signaling plays a crucial role in regulating various physiological processes. It involves the release of acetylcholine (ACh) by parasympathetic neurons, which can have localized and short-lived effects. The majority of ACh released is rapidly inactivated at the synapse by the enzyme acetylcholinesterase (AChE), which hydrolyzes Ach into choline and acetate. Additionally, the tissue cholinesterase deactivates any ACh diffusing into the surrounding tissues.
The effects of...
The effects of...
1.8K
Cholinergic Receptors: Nicotinic
2.5K
Nicotinic receptors are ligand-gated ion channels that are activated by acetylcholine and nicotine. Upon activation, they cause a rapid increase in the permeability of cells to K+, Na+, and Ca2+, followed by depolarization and excitation. They are in the autonomic ganglia, skeletal neuromuscular junction, CNS, and adrenal medulla.
There are two types of nicotinic receptors: neuromuscular (NM/NM/N1) and neuronal (NN/NN/N2). The two families differ based on their location and selectivity to...
There are two types of nicotinic receptors: neuromuscular (NM/NM/N1) and neuronal (NN/NN/N2). The two families differ based on their location and selectivity to...
2.5K
Transducer Mechanism: G Protein–Coupled Receptors
1.9K
G Protein–Coupled Receptors (GPCRs) are membrane-bound receptors that transiently associate with heterotrimeric G proteins and induce an appropriate response to various stimuli. GPCRs regulate critical physiological pathways and are excellent drug targets for treating diseases such as diabetes, cancer, obesity, depression, or Alzheimer's. Nearly 35% of approved drugs implement their therapeutic effects by selectively interacting with specific GPCRs.
GPCRs are also called heptahelical,...
GPCRs are also called heptahelical,...
1.9K
The Two-State Receptor Model
1.9K
The two-state receptor model explains a drug's interaction with receptors, such as G protein-coupled receptors and ligand-gated ion channels, to induce or inhibit a biological response. When no natural ligands are present, a receptor exists in an equilibrium of inactive (Ri) and active (Ra) conformations. The inactive form does not produce a response, while the active form generates a basal effect known as constitutive activity.
The binding affinity of a drug determines its interaction with...
The binding affinity of a drug determines its interaction with...
1.9K
Adrenergic Receptors: β Subtype
1.6K
β-adrenoceptors have varied sensitivities towards adrenaline, noradrenaline, and isoprenaline. The order of agonist potency is as follows:
Isoprenaline > Adrenaline > Noradrenaline
Neurotransmitter binding to these receptors causes activation of adenylyl cyclase resulting in increased concentrations of cAMP and modulation of calcium ion channels within the cell. They are further classified into β1, β2, and β3 subtypes.
β1-adrenoceptors: β1-adrenoceptors...
Isoprenaline > Adrenaline > Noradrenaline
Neurotransmitter binding to these receptors causes activation of adenylyl cyclase resulting in increased concentrations of cAMP and modulation of calcium ion channels within the cell. They are further classified into β1, β2, and β3 subtypes.
β1-adrenoceptors: β1-adrenoceptors...
1.6K

